Valuation Abbott Laboratories Lima
Stocks
ABTUS
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.58 USD | +5.82% |
|
+1.66% | -22.75% |
Company Valuation: Abbott Laboratories
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 241,365 | 191,427 | 191,088 | 196,184 | 217,859 | 182,002 | - | - |
| Change | - | -20.69% | -0.18% | 2.67% | 11.05% | -16.46% | - | - |
| Enterprise Value (EV) 1 | 249,166 | 198,318 | 198,871 | 202,693 | 222,266 | 206,168 | 203,418 | 199,617 |
| Change | - | -20.41% | 0.28% | 1.92% | 9.66% | -7.24% | -1.33% | -1.87% |
| P/E | 35.7x | 28.1x | 33.8x | 14.8x | 33.7x | 29.9x | 23.1x | 20.7x |
| PBR | 6.93x | 5.2x | 4.94x | 4.11x | 4.18x | 3.76x | 3.6x | 3.39x |
| PEG | - | -36.9x | -2x | 0x | -0.7x | -4.89x | 0.8x | 1.8x |
| Capitalization / Revenue | 5.6x | 4.39x | 4.76x | 4.68x | 4.91x | 3.62x | 3.33x | 3.12x |
| EV / Revenue | 5.78x | 4.54x | 4.96x | 4.83x | 5.01x | 4.1x | 3.72x | 3.42x |
| EV / EBITDA | 19.4x | 15.9x | 19.5x | 19.1x | 18.9x | 15.9x | 14.1x | 12.6x |
| EV / EBIT | 22x | 17.7x | 22.3x | 21.8x | 21.6x | 17.6x | 15.6x | 13.9x |
| EV / FCF | 28.8x | 25.4x | 39.3x | 31.9x | 30.1x | 26x | 21.7x | 19.5x |
| FCF Yield | 3.47% | 3.94% | 2.54% | 3.13% | 3.33% | 3.85% | 4.6% | 5.12% |
| Dividend per Share 2 | 1.82 | 1.92 | 2.08 | 2.24 | 2.4 | 2.577 | 2.739 | 2.854 |
| Rate of return | 1.29% | 1.75% | 1.89% | 1.98% | 1.92% | 2.47% | 2.62% | 2.73% |
| EPS 2 | 3.94 | 3.91 | 3.26 | 7.64 | 3.72 | 3.492 | 4.522 | 5.038 |
| Distribution rate | 46.2% | 49.1% | 63.8% | 29.3% | 64.5% | 73.8% | 60.6% | 56.7% |
| Net sales 1 | 43,075 | 43,653 | 40,109 | 41,950 | 44,328 | 50,304 | 54,649 | 58,413 |
| EBITDA 1 | 12,815 | 12,485 | 10,188 | 10,635 | 11,735 | 12,951 | 14,445 | 15,797 |
| EBIT 1 | 11,324 | 11,231 | 8,911 | 9,295 | 10,301 | 11,718 | 13,019 | 14,321 |
| Net income 1 | 7,071 | 6,933 | 5,723 | 13,402 | 6,524 | 6,255 | 7,923 | 8,786 |
| Net Debt 1 | 7,801 | 6,891 | 7,783 | 6,509 | 4,407 | 24,166 | 21,416 | 17,615 |
| Reference price 2 | 140.74 | 109.79 | 110.07 | 113.11 | 125.29 | 104.49 | 104.49 | 104.49 |
| Nbr of stocks (in thousands) | 1,714,968 | 1,743,574 | 1,736,059 | 1,734,455 | 1,738,834 | 1,741,813 | - | - |
| Announcement Date | 1/26/22 | 1/25/23 | 1/24/24 | 1/22/25 | 1/22/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.11x | 3.34x | 11.74x | 3.53% | 108B | ||
| 17.31x | 0.19x | 12.22x | 0.76% | 60.54B | ||
| 31.19x | 7.57x | 19.79x | 1.28% | 50.53B | ||
| 39.6x | 3.14x | 10.7x | 2.42% | 43.79B | ||
| 38.06x | 1.39x | 12.2x | 0.26% | 33.57B | ||
| 29.82x | 5.34x | 17.02x | -.--% | 28.31B | ||
| 38.63x | 6.76x | 24.22x | 0.27% | 23.31B | ||
| 24.05x | 3.51x | 12.63x | 1.21% | 21.28B | ||
| 19.85x | 2.74x | 10.67x | 1.59% | 20.27B | ||
| Average | 28.62x | 3.78x | 14.58x | 1.26% | 43.27B | |
| Weighted average by Cap. | 26.59x | 3.54x | 13.91x | 1.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ABT Stock
- ABTUS Stock
- Valuation Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
















